- The trend backdrop is active with a 14-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
ASTERDM
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Aster DM Healthcare Limited · Healthcare · Medical Care Facilities
Latest close
869.7 INR
5.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 22.9% above the Trend Line and sits at 98.4% of its 52-week range. The latest completed week returned 5.8%, after a 7.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
78
out of 100
Latest Close
869.7 INR
7 Aug 2026
1W Return
5.8%
latest completed week
4W Return
7.5%
short-term follow-through
12W Return
15.4%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
2.8x
vs 13-week average
- 15 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
5.8%
Latest completed week; four-week move 7.5%.
Indicator stack
79/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
23 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 22.9% above the Trend Line and sits at 98.4% of its 52-week range. The latest completed week returned 5.8%, after a 7.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9512-week average 0.91
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1515 reversal markers
No recent accumulation markers. 15 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.5% over four weeks, 15.4% over 12 weeks, and 50.7% over one year. The current trend has remained active for 14 consecutive weeks.
Performance by holding period
Active trend streak14 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change-22.5%Four-week change in activity pressure.
Leadership28.54Latest relative-leadership reading.
RS change14.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength25/100Blend of value, momentum, and quality. Underlying universe rank 76; rank 1 is best.
Value1/100Relative valuation strength. Underlying universe rank 100; rank 1 is best.
Quality69/100Profitability and accounting quality. Underlying universe rank 32; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth16/100Revenue and earnings growth. Underlying universe rank 85; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework8/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 212.3x Price divided by trailing earnings.
- Price / sales
- 17.0x Market value relative to trailing revenue.
- EV / EBITDA
- 88.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 77.4% Gross profit retained from each unit of revenue.
- Operating margin
- 13.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 4.0% Free cash flow generated from revenue.
- Return on invested capital
- 6.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 12.2% Latest one-year revenue growth.
- EPS growth
- -93.0% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 161.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.5% Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.3x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 23 relevant articles.
1 positive · 20 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.6%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher18 of 268 weeks finished lower.
Best week+8.1%Week of 12 Jun.
Worst week-6.0%Week of 20 Mar.
Latest week+5.8%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains11
Flat weeks0
Modest losses5
Sharp losses3
Recent vol3.8%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank21 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank3 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape76/100
Trend, activity pressure, participation, and risk combine to a 76/100 tape read.
Indicator analysis82/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.95; 15 reversal markers Factors44/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 68 SVQF8/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1461.0 of 1585 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 23 relevant articles.
S&P 500 Companies' Quarterly Earnings Growth Eases Amid Healthcare Drop, Oppenheimer Says Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 869.7 INR | 5.8% | 707.4 INR | 491.7 INR | 1.09 | 28.54 | 6.1M | On |
| 31 Jul 2026 | 822.2 INR | 4.6% | 698.8 INR | 487.6 INR | 1.12 | 23.45 | 2.6M | On |
| 24 Jul 2026 | 785.7 INR | -4.2% | 691.8 INR | 483.9 INR | 1.26 | 21.86 | 2.0M | On |
| 17 Jul 2026 | 819.9 INR | 1.4% | 686.1 INR | 480.3 INR | 1.41 | 25.07 | 2.5M | On |
| 10 Jul 2026 | 808.9 INR | 2.0% | 678.6 INR | 476.5 INR | 1.40 | 24.94 | 2.6M | On |
| 3 Jul 2026 | 793.2 INR | 3.1% | 672.3 INR | 472.9 INR | 1.39 | 23.02 | 349.8K | On |
| 26 Jun 2026 | 769.0 INR | -5.0% | 666.9 INR | 469.3 INR | 1.35 | 21.04 | 0 | On |
| 19 Jun 2026 | 809.4 INR | -0.7% | 663.3 INR | 465.7 INR | 1.30 | 28.48 | 812.9K | On |
| 12 Jun 2026 | 815.0 INR | 8.1% | 657.9 INR | 461.9 INR | 1.30 | 32.62 | 1.2M | On |
| 5 Jun 2026 | 754.0 INR | 3.5% | 653.3 INR | 458.1 INR | 1.30 | 25.12 | 233.6K | On |
| 29 May 2026 | 728.3 INR | -3.7% | 651.1 INR | 454.6 INR | 1.41 | 20.77 | 1.7M | On |
| 22 May 2026 | 756.6 INR | 0.4% | 649.4 INR | 451.3 INR | 1.41 | 25.34 | 2.6M | On |
| 15 May 2026 | 753.7 INR | 1.5% | 647.6 INR | 447.7 INR | 1.23 | 26.18 | 5.4M | On |
| 8 May 2026 | 742.4 INR | 5.9% | 645.8 INR | 444.1 INR | 0.97 | 22.35 | 14.6M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.